Episode
Leading with Purpose: Dr. Monica Shah and the American Heart Association's Mission
- Podcast
- Moving Medicine Forward
- Published
- Jan 28, 2026
- Duration seconds
- 1501
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/moving-medicine-forward-6832193/episodes/leading-with-purpose-dr-monica-shah-and-the-american-heart-association-s-mission/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/moving-medicine-forward-6832193/leading-with-purpose-dr-monica-shah-and-the-american-heart-association-s-mission.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of Moving Medicine Forward , Dr. Monica Shah, Chief Medical Officer at CTI and President-Elect of the American Heart Association's Greater Washington Region Board of Directors, reflects on why Wear Red Day holds personal significance to her. Dr. Shah shares her path through cardiology and clinical research, the American Heart Association’s community impact across the region, and the organization’s priorities for advancing equitable care. She also shares her perspective on the future of cell and gene therapies and emphasizes the need for diverse representation in clinical trials. 01:08 Dr. Shah’s path through cardiology, research training at Duke, and career across academia, NIH, and industry. 03:38 Early involvement with the American Heart Association and the fellowship grant that launched her research career. 05:35 Responsibilities and priorities as President‑Elect of the AHA Greater Washington Region Board. 07:00 Leadership development and building a diverse pipeline of future AHA leaders. 08:10 Regional community impact: CPR education, school programs, nutrition initiatives, and policy advocacy. 10:07 Translating the AHA’s national mission into local, lifesaving change - including DC’s CPR Act. 11:32 Hypertension control and partnerships addressing nutrition security. 12:26 Barriers to cardiovascular health and how AHA programs support access and education. 13:22 COVID‑19’s long-term cardiovascular impact and AHA’s research and telehealth initiatives. 14:52 Advocating for equitable representation in clinical trials. 15:59 Emerging opportunities in cell and gene therapy and the importance of genetic testing. 17:34 How public–private partnerships accelerate cardiovascular innovation. 18:55 Advice for early-career clinicians and researchers, especially…